High Tower Advisors, LLC Akari Therapeutics PLC Transaction History

High Tower Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 10, 2022	SELL	$1.38 - $1.74 $27,599 - $34,800	-20,000 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$1.59 - $1.87 $9,540 - $11,220	-6,000 Reduced 23.08%	20,000 $33,000
Q2 2021 Aug 06, 2021	BUY	$1.69 - $2.85 $43,940 - $74,100	26,000 New	26,000 $45,000
Q1 2021 May 10, 2021	SELL	$1.81 - $3.88 $47,060 - $100,880	-26,000 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$1.5 - $2.02 $15,000 - $20,200	10,000 Added 62.5%	26,000 $49,000
Q3 2020 Nov 13, 2020	BUY	$1.58 - $2.37 $25,280 - $37,920	16,000 New	16,000 $27,000
Q2 2020 Aug 10, 2020	SELL	$1.16 - $2.61 $18,560 - $41,760	-16,000 Closed	0 $0
Q1 2020 May 21, 2020	SELL	$1.06 - $2.16 $21,200 - $43,200	-20,000 Reduced 55.56%	16,000 $24,000
Q4 2019 Feb 14, 2020	BUY	$1.69 - $2.16 $35,490 - $45,360	21,000 Added 140.0%	36,000 $64,000
Q3 2019 Nov 12, 2019	BUY	$1.69 - $2.92 $25,350 - $43,800	15,000 New	15,000 $25,000

Ticker AKTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,349,200
Market Cap $145M
Description
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-...

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on High Tower Advisors, LLC with notifications on news.